BROOKDALE SENIOR LIVING INC (BKD) Stock Fundamental Analysis
NYSE:BKD - New York Stock Exchange, Inc. - US1124631045 - Common Stock - Currency: USD
Overall BKD gets a fundamental rating of 2 out of 10. We evaluated BKD against 103 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of BKD have multiple concerns. BKD has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
BKD had negative earnings in the past year.
In the past year BKD had a positive cash flow from operations.
In the past 5 years BKD reported 4 times negative net income.
BKD had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
BKD has a Return On Assets of -3.82%. This is in the lower half of the industry: BKD underperforms 64.08% of its industry peers.
BKD's Return On Equity of -161.77% is on the low side compared to the rest of the industry. BKD is outperformed by 77.67% of its industry peers.
BKD has a Return On Invested Capital of 0.92%. This is comparable to the rest of the industry: BKD outperforms 42.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.82% | ||
| ROE | -161.77% | ||
| ROIC | 0.92% |
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BKD has a Operating Margin (2.07%) which is in line with its industry peers.
BKD's Operating Margin has improved in the last couple of years.
BKD's Gross Margin of 25.92% is in line compared to the rest of the industry. BKD outperforms 50.49% of its industry peers.
In the last couple of years the Gross Margin of BKD has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.07% | ||
| PM (TTM) | N/A | ||
| GM | 25.92% |
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
2. Health
2.1 Basic Checks
BKD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BKD has more shares outstanding
The number of shares outstanding for BKD has been increased compared to 5 years ago.
The debt/assets ratio for BKD has been reduced compared to a year ago.
2.2 Solvency
BKD has an Altman-Z score of -0.22. This is a bad value and indicates that BKD is not financially healthy and even has some risk of bankruptcy.
BKD has a Altman-Z score of -0.22. This is in the lower half of the industry: BKD underperforms 79.61% of its industry peers.
A Debt/Equity ratio of 29.13 is on the high side and indicates that BKD has dependencies on debt financing.
BKD has a Debt to Equity ratio of 29.13. This is amonst the worse of the industry: BKD underperforms 86.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 29.13 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.22 |
ROIC/WACC0.11
WACC8.05%
2.3 Liquidity
BKD has a Current Ratio of 0.82. This is a bad value and indicates that BKD is not financially healthy enough and could expect problems in meeting its short term obligations.
BKD has a worse Current ratio (0.82) than 79.61% of its industry peers.
A Quick Ratio of 0.82 indicates that BKD may have some problems paying its short term obligations.
BKD's Quick ratio of 0.82 is on the low side compared to the rest of the industry. BKD is outperformed by 72.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
The earnings per share for BKD have decreased strongly by -35.06% in the last year.
Looking at the last year, BKD shows a small growth in Revenue. The Revenue has grown by 3.65% in the last year.
BKD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.08% yearly.
EPS 1Y (TTM)-35.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.38%
Revenue 1Y (TTM)3.65%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.96%
3.2 Future
BKD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.30% yearly.
BKD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.26% yearly.
EPS Next Y16.78%
EPS Next 2Y20.4%
EPS Next 3Y17.3%
EPS Next 5YN/A
Revenue Next Year2.37%
Revenue Next 2Y-0.64%
Revenue Next 3Y1.26%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BKD. In the last year negative earnings were reported.
Also next year BKD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BKD is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 13.56 |
4.3 Compensation for Growth
A more expensive valuation may be justified as BKD's earnings are expected to grow with 17.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.4%
EPS Next 3Y17.3%
5. Dividend
5.1 Amount
No dividends for BKD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.93
+0.19 (+2.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners99.94%
Inst Owner Change0%
Ins Owners0.8%
Ins Owner Change0.06%
Market Cap1.86B
Analysts72
Price Target7.4 (-6.68%)
Short Float %3.57%
Short Ratio2.76
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-109.89%
Min EPS beat(2)-145.33%
Max EPS beat(2)-74.45%
EPS beat(4)0
Avg EPS beat(4)-64.42%
Min EPS beat(4)-145.33%
Max EPS beat(4)-12.21%
EPS beat(8)2
Avg EPS beat(8)-28.12%
EPS beat(12)4
Avg EPS beat(12)-12.37%
EPS beat(16)7
Avg EPS beat(16)8.7%
Revenue beat(2)0
Avg Revenue beat(2)-1.23%
Min Revenue beat(2)-1.36%
Max Revenue beat(2)-1.1%
Revenue beat(4)0
Avg Revenue beat(4)-1.16%
Min Revenue beat(4)-1.36%
Max Revenue beat(4)-1%
Revenue beat(8)0
Avg Revenue beat(8)-0.94%
Revenue beat(12)0
Avg Revenue beat(12)-0.82%
Revenue beat(16)0
Avg Revenue beat(16)-1.14%
PT rev (1m)0%
PT rev (3m)5.07%
EPS NQ rev (1m)3.53%
EPS NQ rev (3m)-3.41%
EPS NY rev (1m)-18.28%
EPS NY rev (3m)-26.44%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)0.3%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)-0.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.59 | ||
| P/FCF | N/A | ||
| P/OCF | 9.74 | ||
| P/B | 12.67 | ||
| P/tB | 15.56 | ||
| EV/EBITDA | 13.56 |
EPS(TTM)-1.04
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-1.82
FCFYN/A
OCF(TTM)0.81
OCFY10.26%
SpS13.47
BVpS0.63
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.82% | ||
| ROE | -161.77% | ||
| ROCE | 1.16% | ||
| ROIC | 0.92% | ||
| ROICexc | 0.96% | ||
| ROICexgc | 0.96% | ||
| OM | 2.07% | ||
| PM (TTM) | N/A | ||
| GM | 25.92% | ||
| FCFM | N/A |
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y47.69%
ROICexc growth 3YN/A
ROICexc growth 5Y48.52%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
F-Score4
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 29.13 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.73 | ||
| Cap/Depr | 165.39% | ||
| Cap/Sales | 19.58% | ||
| Interest Coverage | 0.27 | ||
| Cash Conversion | 43.42% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | -0.22 |
F-Score4
WACC8.05%
ROIC/WACC0.11
Cap/Depr(3y)69.44%
Cap/Depr(5y)87.89%
Cap/Sales(3y)8.28%
Cap/Sales(5y)9.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.38%
EPS Next Y16.78%
EPS Next 2Y20.4%
EPS Next 3Y17.3%
EPS Next 5YN/A
Revenue 1Y (TTM)3.65%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.96%
Revenue Next Year2.37%
Revenue Next 2Y-0.64%
Revenue Next 3Y1.26%
Revenue Next 5YN/A
EBIT growth 1Y82.52%
EBIT growth 3YN/A
EBIT growth 5Y46.37%
EBIT Next Year528.24%
EBIT Next 3Y95.37%
EBIT Next 5YN/A
FCF growth 1Y-163.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y276.93%
OCF growth 3YN/A
OCF growth 5Y-5.14%